Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.

Proteomic analysis of peripheral leukocytes in Alzheimer's disease patients treated with divalproex sodium.

Mhyre TR, Loy R, Tariot PN, Profenno LA, Maguire-Zeiss KA, Zhang D, Coleman PD, Federoff HJ.

Neurobiol Aging. 2008 Nov;29(11):1631-43. Epub 2007 May 22.

2.
3.

Proteomic profiling and neurodegeneration in Alzheimer's disease.

Tsuji T, Shiozaki A, Kohno R, Yoshizato K, Shimohama S.

Neurochem Res. 2002 Oct;27(10):1245-53.

PMID:
12462422
4.

Proteomics analysis of the Alzheimer's disease hippocampal proteome.

Sultana R, Boyd-Kimball D, Cai J, Pierce WM, Klein JB, Merchant M, Butterfield DA.

J Alzheimers Dis. 2007 May;11(2):153-64.

PMID:
17522440
5.

Early dysregulation of the mitochondrial proteome in a mouse model of Alzheimer's disease.

Chou JL, Shenoy DV, Thomas N, Choudhary PK, Laferla FM, Goodman SR, Breen GA.

J Proteomics. 2011 Apr 1;74(4):466-79. doi: 10.1016/j.jprot.2010.12.012. Epub 2011 Jan 13.

PMID:
21237293
6.

Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.

Zamora DO, Riviere M, Choi D, Pan Y, Planck SR, Rosenbaum JT, David LL, Smith JR.

Mol Vis. 2007 Oct 30;13:2058-65.

PMID:
18079679
7.

Proteome-based plasma biomarkers for Alzheimer's disease.

Hye A, Lynham S, Thambisetty M, Causevic M, Campbell J, Byers HL, Hooper C, Rijsdijk F, Tabrizi SJ, Banner S, Shaw CE, Foy C, Poppe M, Archer N, Hamilton G, Powell J, Brown RG, Sham P, Ward M, Lovestone S.

Brain. 2006 Nov;129(Pt 11):3042-50.

8.

Abnormal accumulation of citrullinated proteins catalyzed by peptidylarginine deiminase in hippocampal extracts from patients with Alzheimer's disease.

Ishigami A, Ohsawa T, Hiratsuka M, Taguchi H, Kobayashi S, Saito Y, Murayama S, Asaga H, Toda T, Kimura N, Maruyama N.

J Neurosci Res. 2005 Apr 1;80(1):120-8.

PMID:
15704193
9.

Accumulation of neutral lipids in peripheral blood mononuclear cells as a distinctive trait of Alzheimer patients and asymptomatic subjects at risk of disease.

Pani A, Mandas A, Diaz G, Abete C, Cocco PL, Angius F, Brundu A, Muçaka N, Pais ME, Saba A, Barberini L, Zaru C, Palmas M, Putzu PF, Mocali A, Paoletti F, La Colla P, Dessì S.

BMC Med. 2009 Nov 2;7:66. doi: 10.1186/1741-7015-7-66.

10.

Oligomeric beta-amyloid(1-42) induces the expression of Alzheimer disease-relevant proteins in cholinergic SN56.B5.G4 cells as revealed by proteomic analysis.

Joerchel S, Raap M, Bigl M, Eschrich K, Schliebs R.

Int J Dev Neurosci. 2008 May-Jun;26(3-4):301-8. doi: 10.1016/j.ijdevneu.2008.01.004. Epub 2008 Jan 19.

PMID:
18325718
11.

Proteomics analysis reveals novel components in the detergent-insoluble subproteome in Alzheimer's disease.

Gozal YM, Duong DM, Gearing M, Cheng D, Hanfelt JJ, Funderburk C, Peng J, Lah JJ, Levey AI.

J Proteome Res. 2009 Nov;8(11):5069-79. doi: 10.1021/pr900474t.

12.

Proteomic analysis of cerebral synaptosomes isolated from rat model of alzheimer's disease.

Yang H, Qiao H, Tian X.

Indian J Exp Biol. 2011 Feb;49(2):118-24.

PMID:
21428213
13.

Proteome analysis of brain proteins in Alzheimer's disease: subproteomics following sequentially extracted protein preparation.

Shiozaki A, Tsuji T, Kohno R, Kawamata J, Uemura K, Teraoka H, Shimohama S.

J Alzheimers Dis. 2004 Jun;6(3):257-68.

PMID:
15201480
14.

A two-dimensional protein fragmentation-proteomic study of neuronal ceroid lipofuscinoses: identification and characterization of differentially expressed proteins.

Wang P, Ju W, Wu D, Wang L, Yan M, Zou J, He B, Jenkins EC, Brown WT, Zhong N.

J Chromatogr B Analyt Technol Biomed Life Sci. 2011 Feb 15;879(5-6):304-16. doi: 10.1016/j.jchromb.2010.12.011. Epub 2010 Dec 23.

PMID:
21242110
15.

Divalproex sodium in nursing home residents with possible or probable Alzheimer Disease complicated by agitation: a randomized, controlled trial.

Tariot PN, Raman R, Jakimovich L, Schneider L, Porsteinsson A, Thomas R, Mintzer J, Brenner R, Schafer K, Thal L; Alzheimer's Disease Cooperative Study; Valproate Nursing Home Study Group.

Am J Geriatr Psychiatry. 2005 Nov;13(11):942-9.

PMID:
16286437
16.
17.

Glycosylation changes in Alzheimer's disease as revealed by a proteomic approach.

Kanninen K, Goldsteins G, Auriola S, Alafuzoff I, Koistinaho J.

Neurosci Lett. 2004 Sep 2;367(2):235-40.

PMID:
15331161
18.

[Effect of Bizhongxiao decoction on proteomics of peripheral blood mononuclear cells in patients with rheumatoid arthritis].

Jiang YQ, Liang QH, Xiong XG.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Nov;30(11):1160-4. Chinese.

PMID:
21275167
19.

Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part I: creatine kinase BB, glutamine synthase, and ubiquitin carboxy-terminal hydrolase L-1.

Castegna A, Aksenov M, Aksenova M, Thongboonkerd V, Klein JB, Pierce WM, Booze R, Markesbery WR, Butterfield DA.

Free Radic Biol Med. 2002 Aug 15;33(4):562-71.

PMID:
12160938
20.

Low-dose divalproex in agitated patients with Alzheimer's disease.

Dolder C, McKinsey J.

J Psychiatr Pract. 2010 Jan;16(1):63-7. doi: 10.1097/01.pra.0000367781.26507.86.

PMID:
20098234
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk